sábado, 9 de diciembre de 2023

MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers

https://www.news-medical.net/news/20231208/MD-Anderson-and-Rigel-partner-to-expand-olutasidenib-evaluation-in-AML-and-other-cancers.aspx

No hay comentarios:

Publicar un comentario